Photo of Eric Swalwell
D United States House · District 14 · California

Rep. Eric Swalwell

Compare
Total votes
2,631
all sessions
Attendance
88%
303 missed
Lower than 99% of chamber peers
With party
97%
of cast votes
Near the chamber average
Bipartisan score
1%
crosses aisle rarely
Near the chamber average
Sponsored
1,416
bills & resolutions
Near the chamber average
Committees
0
assignments
1,416 bills and resolutions

Sponsored bills

Total
1,416
Primary
46
Co-sponsor
1,370
This page
1,416
matching current filters
Co-sponsor HRES 591
In committee · United States House · Co-sponsor
Expressing support for the recognition of August 22 through 28, 2021, as Wildfire Preparedness Week, the national event educating the public on fire safety and preparedness, and supporting the goals of a Wildfire Preparedness Week.

This resolution supports (1) the goals of Wildfire Preparedness Week, and (2) resources and educational initiatives that communicate how affected communities can prevent wildfires and react during a wildfire.

In committee Aug 18, 2021 1 co-sponsor
Co-sponsor HR 5030
In committee · United States House · Co-sponsor
DIVERSE Trials Act

Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act or the DIVERSE Trials Act This bill requires activities to increase diversity in clinical trials. It also expands reporting by laboratories that test for and diagnose COVID-19 and requires a study on data collection and data sharing during public health emergencies. Specifically, the Food and Drug Administration (FDA) must issue guidance on decentralized clinical trials to promote meaningful demographic and geographic diversity in patient engagement, enrollment, and participation. Decentralized clinical trials include those executed through telemedicine or other digital technologies to allow for the remote collection and assessment of clinical trial data. The FDA may also work with foreign regulators to harmonize international regulations governing decentralized clinical trials and the use of digital health technology. In addition, the Department of Health and Human Services (HHS) may support community education, outreach, and recruitment activities for clinical trials of treatments for conditions that disproportionately impact populations underrepresented in clinical trials. The bill also specifies that drug or device manufacturers may provide, subject to some limits, free digital health technologies and other remuneration to patients in approved clinical trials without violating laws that address fraud and abuse in federal programs. Furthermore, laboratories that test for and diagnose COVID-19 must report additional demographic data, including information about social determinants of health. HHS must also contract with the National Academy of Medicine to study and propose a design for an interoperable platform to facilitate data sharing during public health emergencies.

In committee Aug 16, 2021 1 co-sponsor
Primary HR 5033
In committee · United States House · Lead sponsor
Rare Earth Magnet Manufacturing Production Tax Credit Act of 2021

Rare Earth Magnet Manufacturing Production Tax Credit Act of 2021 This bill allows a new tax credit for the domestic production of rare earth magnets manufactured in the ordinary course of a taxpayer's trade or business. The bill defines rare earth magnet as a permanent magnet comprised of (1) an alloy of neodymium, praseodymium, iron, boron, terbium, or dysprosium; or (2) an alloy of samarium, gadolinium, and cobalt.

In committee Aug 13, 2021 0 co-sponsors
Co-sponsor HR 4680
In committee · United States House · Co-sponsor
Fair Sugar Policy Act of 2021

Fair Sugar Policy Act of 20 21 This bill makes several modifications to the Department of Agriculture's sugar program. Among other modifications, the bill decreases the rate for price support loans, repeals the marketing allotments, revises the administration of import quotas, and repeals the Feedstock Flexibility Program.

In committee Aug 13, 2021 1 co-sponsor
Primary HR 4492
In committee · United States House · Lead sponsor
Biosecurity Information Optimization for Defense Act of 2021

Biosecurity Information Optimization for Defense Act of 2021 This bill directs the President to establish a cabinet-level interagency forum to be known as the National Biodefense Directorate. The directorate must develop a (1) national biodefense strategy and implementation plan, and (2) national strategy for combating public health misinformation and disinformation that threatens the national security and associated implementation plan. The directorate must submit to the National Security Council and Congress a report including the National Biodefense Strategy and associated implementation plans. The Government Accountability Office must review the report and submit to Congress a report that identifies gaps in such strategies and plans and that makes recommendations to address such gaps.

In committee Aug 11, 2021 0 co-sponsors
Co-sponsor HR 4974
In committee · United States House · Co-sponsor
State Public Option Act

State Public Option Act This bill allows residents who are not already eligible for Medicaid and not concurrently enrolled in other health insurance coverage to buy into a state Medicaid plan beginning January 1, 2022, at the option of the state. State Medicaid programs may set premiums and cost-sharing requirements for such coverage in accordance with specified limitations. The bill also (1) provides the enhanced Federal Medical Assistance Percentage (i.e., federal matching rate) to every state that expands Medicaid coverage for individuals who are newly eligible under the Patient Protection and Affordable Care Act, regardless of when such expansion takes place; and (2) requires state Medicaid programs to cover comprehensive reproductive health care services, including abortion services.

In committee Aug 9, 2021 1 co-sponsor
Co-sponsor HR 4980
In committee · United States House · Co-sponsor
To direct the Secretary of Homeland Security to ensure that any individual traveling on a flight that departs from or arrives to an airport inside the United States or a territory of the United States is fully vaccinated against COVID-19, and for other purposes.

This bill directs the Transportation Security Administration (TSA) to ensure that any individual traveling on a flight that departs from or arrives to an airport inside the United States or a U.S. territory is fully vaccinated against COVID-19. The TSA must also ensure that there is an exception to the requirement for an individual who is ineligible or medically unable to be fully vaccinated against COVID-19.

In committee Aug 7, 2021 1 co-sponsor
Showing 1,151 to 1,160 of 1,416 bills